Delivery Order SPE2DB22D3301-SPE2DB24FY4HD
Award Date 4/9/24
Potential Completion Date 4/30/24
Potential Value $42K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $32,446.89, is for the delivery of POLIVY 140 MG VIALS, a pharmaceutical product, with a completion date of December 18, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,046.06, is a Firm Fixed Price Delivery Order to provide POLIVY 140 MG VIALS to support military healthcare programs. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. This award is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $20,908.66 firm fixed price delivery order is for the supply of 4563344425 POLIVY 140 MG VIALS. The contract has a completion date of February 7, 2024 and was awarded on January 17, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office...
- This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp's Corporate Office Division. The $32,817.12 delivery order contract is for the provision of POLIVY 140 MG VIALS, a pharmaceutical product. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various federal agencies, particularly the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,849.74 to AmerisourceBergen Drug Corp for the supply of Polivy 140 mg vials, with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order, issued on December 29, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,631.26 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS, with a period of performance through December 18, 2024. This contract is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,849.74 to AmerisourceBergen Drug Corp for the supply of Polivy 140 mg vials, with an ultimate completion date of January 22, 2026. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the major pharmaceutical distributor and healthcare solutions provider. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,023.03 to AmerisourceBergen Drug Corp for 140 mg vials of Polivy, a pharmaceutical product, with performance at the contractor's Conshohocken, Pennsylvania location. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under...
- The Defense Logistics Agency awarded a delivery order valued at $22,046.06 to AmerisourceBergen Drug Corp for the supply of Polivy 140 mg vials, with an ultimate completion date of November 28, 2025. This is a firm fixed-price, non-set-aside contract issued on November 5, 2025, with performance at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $22,046.06 to AmerisourceBergen Drug Corp for the supply of Polivy 140 mg vials, with an ultimate completion date of October 9, 2025. This firm fixed-price contract, awarded on September 18, 2025, represents a non-competitive, non-set-aside delivery order issued against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor vehicle running...